Brand name and generic companies jockey for off-patent business position

Article Abstract:

Several generic companies are shifting towards brand-name market, despite the continuous increase in sales of generic products in the prescription pharmaceutical market. Estimates show that generic pharmaceutical business will grow to $15 to $20 billion industry by 2006 from $8 billion and $9 billion in 1998. The growth will come from brand products, which face patent or exclusivity expiration in the next 10 years. Meanwhile, brand-name companies, which in early 1990s were actively participating in generic business, are now dropping out of the generic business. One factor why brand companies are getting out of the generic business is that new patents and legislations are allowing several companies to prolong the life of certain brand products.

Market information - general, Generic Drugs

---

Finally, predictable returns on promotional investments

Article Abstract:

Manufacturers of prescription pharmaceuticals face the need to effectively manage their marketing initiatives to achieve success amidst the market's business climate. Promotion and sales initiatives have emerged as equally important compared to new-drug research and development efforts, with the introduction of a product into a market securing greater emphasis from manufacturers. Prescription-drugs companies can avail of research organizations' combination of sophisticated software and innovative techniques to optimize on their promotion spending and to gauge and predict the returns from their promotional investments.

Promotion

---

Negotiating the rate card

Article Abstract:

Johnson & Johnson, a large prescription drug manufacturer, is being criticized by medical journal publishers over its request for a 20% to 25% hike in advertising value. One insider noted that this is equivalent to discounts. Another publisher indicated that this signifies consumer power over industry policies. Johnson & Johnson is trying to make the most of advertising-related expenditures by consolidating professional media-buying operations. Others stressed that the company may be demanding too much from the industry by issuing the company's request on short notice.

Periodical Publishers, Public affairs, Strategic alliances, Medical Equipment and Supplies Manufacturing, Regulation/Ethics, Medical Instruments & Supplies, Medical Periodicals, Medical equipment industry, Johnson & Johnson, Medical journals

Similar abstracts:

• Abstracts: Who gains and who loses with community rating for small business? Is the individual market more than a bridge market? An analysis of disenrollment decisions
• Abstracts: Capitation contracts: access and quality. Efficient computation of partial expected value of sample information using Bayesian approximation
• Abstracts: Home-grown HMOs. Taking care of business. The urban frontier
• Abstracts: Mean streets: five lessons from the front lines of reengineering. Franklin Regional Hospital: Franklin, New Hampshire: small hospital thrives while pushing its walls into the community
• Abstracts: Understanding hospital referrals to home health agencies. Discriminant analysis: a technique for adding value to patient satisfaction surveys

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.